MTOR and cutaneous melanoma: EGFR also has potential as an important therapeutic target in human cancer because it may be involved in the progression of cutaneous melanomas specifically [77] and more generally acts upstream of mTOR as a signal transducer of mitogens, which play a role in cancer pathogenesis and development [78].